These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3632741)

  • 1. Effect of long-term clofibric acid treatment on serum and tissue lipid and cholesterol levels in obese Zucker rats.
    Cleary MP; Kasiske B; O'Donnell MP; Keane WF
    Atherosclerosis; 1987 Jul; 66(1-2):107-12. PubMed ID: 3632741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of dehydroepiandrosterone and clofibric acid treatments in obese Zucker rats.
    Mohan PF; Cleary MP
    J Nutr; 1989 Mar; 119(3):496-501. PubMed ID: 2564047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research regarding the action of a derivative of the clofibric acid series on lipid metabolism].
    Filip M; Păduraru I; Hriscu A; Neacşu R; Dănilă G; Filip F
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(2):341-5. PubMed ID: 3685700
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure.
    Kasiske BL; O'Donnell MP; Garvis WJ; Keane WF
    Circ Res; 1988 Feb; 62(2):367-74. PubMed ID: 3338121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term administration of clofibric acid on peroxisomal beta-oxidation, fatty acid-binding protein and cytosolic long-chain acyl-CoA hydrolases in rat liver.
    Kawashima Y; Katoh H; Watanuki H; Takegishi M; Kozuka H
    Biochem Pharmacol; 1985 Feb; 34(3):325-9. PubMed ID: 2857564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of palmitoyl-CoA chain elongation by clofibric acid in the liver of Zucker fa/fa rats.
    Toyama T; Kudo N; Mitsumoto A; Kawashima Y
    Lipids; 2005 May; 40(5):463-70. PubMed ID: 16094855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term moderate food restriction on growth, serum factors, lipogenic enzymes and adipocyte glucose metabolism in lean and obese Zucker rats.
    Cleary MP; Muller S; Lanza-Jacoby S
    J Nutr; 1987 Feb; 117(2):355-60. PubMed ID: 3550007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofibrate, clofibric acid and respective glycinate derivatives. Effects of a four-week treatment on male lean and obese Zucker rats.
    Lupp A; Karge E; Deufel T; Oelschlägers H; Fleck C
    Arzneimittelforschung; 2008; 58(5):225-41. PubMed ID: 18589557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of clofibric acid and tiadenol on cytosolic long-chain acyl-CoA hydrolase and peroxisomal beta-oxidation in liver and extrahepatic tissues of rats.
    Katoh H; Kawashima Y; Watanuki H; Kozuka H; Isono H
    Biochim Biophys Acta; 1987 Jul; 920(2):171-9. PubMed ID: 2886154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats.
    Kasiske BL; O'Donnell MP; Cleary MP; Keane WF
    Kidney Int; 1988 Mar; 33(3):667-72. PubMed ID: 3367557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies with etofibrate in the rat. Part II: A comparison of the effects of prolonged and acute administration on plasma lipids, liver enzymes and adipose tissue lipolysis.
    Bocos C; Castro M; Quack G; Herrera E
    Biochim Biophys Acta; 1993 Jul; 1168(3):340-7. PubMed ID: 8323974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats.
    Petit D; Bonnefis MT; Rey C; Infante R
    Atherosclerosis; 1988 Dec; 74(3):215-25. PubMed ID: 3240333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies with etofibrate in the rat. Part I: Effects on glycerol, free fatty acid and triacylglycerol metabolism.
    Herrera E; Lasunción MA; Castro M; Gómez-Coronado D; Martín A; Quack G
    Biochim Biophys Acta; 1988 Nov; 963(1):42-52. PubMed ID: 3179329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clofibrate and clofibric acid: comparison of the metabolic disposition in rats and dogs.
    Cayen MN; Ferdinandi ES; Greselin E; Robinson WT; Dvornik D
    J Pharmacol Exp Ther; 1977 Jan; 200(1):33-43. PubMed ID: 833760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fructose feeding on lipid parameters in obese and lean, diabetic and nondiabetic Zucker rats.
    Koh ET; Mueller J; Osilesi O; Knehans A; Reiser S
    J Nutr; 1985 Oct; 115(10):1274-84. PubMed ID: 3900313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term administration of clofibric acid on stearoyl-CoA desaturase, 1-acylglycerophosphorylcholine acyltransferase and fatty acyl composition of microsomal phosphatidylcholine in rat liver.
    Hirose A; Kawashima Y; Kozuka H
    Biochem Pharmacol; 1987 Apr; 36(8):1209-14. PubMed ID: 2885002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary clofibric acid increases intestinal fatty acid binding protein activity and apparent lipid digestibility in weanling swine.
    Reinhart GA; Mahan DC; Lepine AJ; Simmen FA; Moore BE
    J Anim Sci; 1993 Oct; 71(10):2693-9. PubMed ID: 8226370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum adipokine profile and fatty acid composition of adipose tissues are affected by conjugated linoleic acid and saturated fat diets in obese Zucker rats.
    Martins SV; Lopes PA; Alfaia CM; Rodrigues PO; Alves SP; Pinto RM; Castro MF; Bessa RJ; Prates JA
    Br J Nutr; 2010 Mar; 103(6):869-78. PubMed ID: 19878618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of clofibric acid and bezafibrate administration on activities of alkaline phosphatase and other enzymes in livers of rats.
    Walli AK; Seidel D
    Res Exp Med (Berl); 1981; 179(2):153-61. PubMed ID: 7280363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of weight gain by glucagon in obese Zucker rats.
    Chan EK; Mackey MA; Snover DC; Schneider PD; Rucker RD; Allen CE; Buchwald H
    Exp Mol Pathol; 1984 Jun; 40(3):320-7. PubMed ID: 6723936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.